Generate a tailored SOP for Dr. David Denning. Improve your application with a focused, well-structured draft.
David Denning is a retired physician with extensive expertise in fungal infections, particularly aspergillosis and antifungal resistance. He graduated from Guys Hospital, London, in 1980 and completed his medical training in various specializations, including infectious diseases and clinical microbiology. He has over 800 research publications focused on fungal diseases and is recognized as a highly cited author, with a Google H-index of 138. Denning led the National Aspergillosis Centre from 2009 to 2020 and has been a primary investigator in numerous major studies, particularly in antifungal drug development and diagnostics. His research interests also include the burden of fungal diseases, antifungal drug resistance, and chronic allergic pulmonary aspergillosis. Denning's collaborations with significant research institutions, including the JC Venter Institute and various pharmaceutical companies, highlight his commitment to advancing fungal disease treatment and understanding. He has received numerous awards, including the Edouard Drouhet Medal. He is the founding president of the Global Action Fungal Infections, focusing on advocacy for fungal disease awareness and research funding. Denning's work contributes significantly to the understanding and treatment of fungal infections globally.
Manchester Fungal Infection Group • Manchester
Leads research on fungal infections, focusing on aspergillosis and antifungal drug resistance.
National Aspergillosis Centre • Manchester
Oversaw the management and research of antifungal treatments and patient care in fungal infections.
Includes MSc in Advanced Electrical Power Systems and MSc in Communications and Signal Processing.